Trending
September 19, 2023 Interview with Adam Low, CEO of SENTA PartnersAugust 2, 2023 Alexandria Venture Investments Join $31 Million Seed Funding For Solu TherapeuticsAugust 1, 2023 Solu Therapeutics Closes of $31 Million Seed FundingJune 27, 2023 Precision for Medicine Acquires Baseline ControlsJune 26, 2023 Duos Raises $10 Million to Enable Older Adults Live Independently
Featured

September 19, 2023
Interview with Adam Low, CEO of SENTA Partners
Adam joined SENTA partners on May 6, 2019 as its Chief Executive Officer. In this role, Adam is responsible for the... Read more »

August 2, 2023
Alexandria Venture Investments Join $31 Million Seed Funding For Solu Therapeutics
BOSTON–(BUSINESS WIRE)–Solu Therapeutics, a precision-medicine company developing therapeutics to eliminate... Read more »

August 1, 2023
Solu Therapeutics Closes of $31 Million Seed Funding
BOSTON--(BUSINESS WIRE)--Solu Therapeutics, a precision-medicine company developing therapeutics to eliminate... Read more »
